Torrent Pharmaceuticals Limited (TORNTPHARM) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally.
Total Assets Chart for Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited (TORNTPHARM) total assets for FY2026 were INR 443.1B, a 195.6% change from FY2025. Torrent Pharmaceuticals Limited's total assets grew from INR 7.1B in 2005 to INR 443.1B in 2026 (6135.5% over 21 years). Total assets compound annual growth rate: 5-year CAGR of 25.8%, 10-year CAGR of 17.3%, 20-year CAGR of 21.2%.
Total Assets (Indian Rupees)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- ₹1.90T
- Implied Share Price
- ₹4999.00
- Enterprise Value
- ₹1.99T
- Revenue (TTM)
- ₹157.23B
- EBITDA
- ₹48.13B
- Profit Margin
- 13.87%
- Trailing P/E
- 79.87
- Forward P/E
- 56.50
- Price/Book (MRQ)
- 22.17
- Price/Sales (TTM)
- 12.09
- EV/EBITDA
- 39.64
- EV/Revenue
- 12.85
- Dividend Yield
- 0.00%
- Book Value
- ₹247.85
- Free Cash Flow (FY2026)
- ₹19.55B
- Free Cash Flow Yield
- 1.03%
Snapshot as of 27th August 2026 — not point-in-time controlled, may lag the live market by a few days.